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ABSTRACT
 Background: The Affordable Care Act (ACA) aimed at making health care 
affordable and accessible including the use of preventive care services. To achieve these 
aims, the ACA expanded Medicaid coverage to population with income below 138% of 
FPL and removed cost-sharing when using preventive care services recommended by the 
USPSTF. This study tried to assess the impact of these provisions on the rate of 
mammography and Pap tests among women. Methods: Data was obtained from the 
Medical Expenditure Panel Survey - Household Component MEPS-HC. A difference-in-
difference design was used to determine the effect of Medicaid eligibility expansion on 
the outcomes and a counterfactual analysis was used to determine the effect of removing 
cost-sharing from preventive care services on the outcomes. Results: The difference-in-
difference estimate show that likelihood of utilizing mammograms did not change 
significantly among low-income women after the implementation of the Medicaid 
expansion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test decreased 
(coefficient -0.0615, t-statistics -2.76), and Medicaid enrollment has increased 
significantly among low-income women living in expansion states (coefficient 0.0889 
with t-value of 3.68). The counterfactual analysis show that the utilization of 
mammogram and pap test did not improve following the ACA. Conclusion: The ACA 
was associated with increased Medicaid enrollment but did not yield near-term 
improvement in use of mammography and Pap tests among women.  Factors beyond 
health insurance coverage may be important in determining the likelihood of obtaining 
vi 
these screening procedures and policy makers should try to identify other barriers to 
cancer screening services utilization among the low-income women in the USA. 
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CHAPTER 1 
INTRODUCTION 
 
In March 2010, the Patient Protection and Affordable Care Act, often shortened to 
the Affordable Care Act (ACA) was signed into law. Major aims of the ACA were to 
make health care affordable and to increase the use of preventive care services, and in 
turn, reduce costly events from poorly or unmanaged chronic conditions. To achieve 
these aims, the ACA expanded Medicaid coverage to include the entire population aged 
18-64 with income below 138% of the federal poverty line and removed cost-sharing 
when using preventive care services recommended by the US Preventive Services Task 
Force (USPSTF) (1). The percentage of American women who receive mammograms 
and pap tests has been suboptimal in the years before the ACA (2). It has been 
documented in the literature that cost-sharing or health insurance are associated with the 
use of medical services including preventive care services (3–15). This study tried to 
assess the impact of these ACA’s provisions on mammograms and Pap tests rates among 
women. 
1.1 BACKGROUND  
Mammography 
Breast cancer is the most commonly diagnosed cancer among American women, 
besides skin cancer (16). Death rates from breast cancer are higher than those for any 
other cancer, besides lung cancer. In 2018, there will be an estimated 266,120 new cases 
2 
of invasive breast cancer diagnosed in women and 41,400 deaths in the US (16). Women 
who appropriately screen for breast cancer are likely to receive more timely diagnosis 
and treatment (16–21). Mammography is the most widely used screening modality for the 
detection of breast cancer. Results from randomized controlled trials and observational 
studies found that mammography reduces the risk of dying from breast cancer (19–21). 
However, mammograms do have risks. Sometimes mammograms find false positives that 
carry risks including pain, anxiety, and other side effects. Experts make trade-offs 
between benefits and risks when making recommendations about who should be 
screened. Establishing age-appropriate guidelines for screening women for breast cancer 
is debated by experts in the medical field. There is evidence that mammogram decrease 
breast cancer mortality among women aged 50-69 but the benefit of mammography for 
women aged 40-49 years is uncertain (22,23). The American cancer society recommends 
beginning annual mammography at the age of 40. This was updated in 2015 to increase 
the starting age to 45. The 2002 guidelines by the US Preventive Services Task Force 
(USPSTF) suggests mammography for women of age 40 years or more, with or without 
clinical breast examination, every 1 to 2 years. This was updated in 2009 which 
recommends mammogram for women aged 50-75 every two years. The ACA utilizes the 
2002 US Preventive Services Task Force (USPSTF) recommendation on breast cancer 
(24). 
Pap tests  
Cervical cancer incidence rates declined by half between 1975 and 2014 due to 
the widespread uptake of the Pap test. However, declines have slowed down in recent 
years. In 2018, there will be an estimated 13,240 new cases of invasive cervical cancer 
3 
diagnosed in women and 4,170 deaths in the US (16). Many women getting regular pap 
tests, which can find cervical precancer before it turns into cancer, have reduced the 
number of cases of cervical cancer and the number of deaths from cervical cancer 
(25,26). Similar to mammograms, pap tests sometimes come with harm when abnormal 
results lead to vaginal bleeding, pain, infection, and anxiety. However, the USPSTF 
concludes that for women aged 21 to 65 years, there is high certainty that the benefits of 
screening with pap test every three years substantially outweigh the harms (27). The 
American cancer society and the USPSTF recommend pap tests for women aged 21-65 
every 3 years or if aged 30-65 pap test combined with HPV screening is recommended 
every 5 years. 
Despite evidence that screening greatly improves health outcomes, rates of 
mammography and pap test screenings remained suboptimal in the United States in the 
years preceding the ACA (2). The percentage of American women who receive 
mammograms has remained steady whereas the percentage of women who receive Pap 
tests has declined slightly. In 2015, 65.3% of women aged 40 and older had a 
mammogram within two years, while 69% of women aged 18 and older had a pap test 
within three years (2). Within the low-income women, 54.9% received mammography 
while 60% received pap test (2). The National Cancer Institute's (NCI) goals include 
increasing the proportion of women who get regular mammograms to 80%, and similar 
goals have been issued for pap tests. 
There are disparities in breast and cervical cancer screenings, diagnosis, and 
outcomes in terms of income, education, race, and health insurance (16,28–36). For 
example, black and Hispanic women and women without private insurance are less likely 
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than white women and women with private insurance to obtain high-quality 
mammography screening (33). A study showed that black and Hispanic women continue 
to be diagnosed at a later stage of breast cancer compared to white women (34). 
Regardless of race,  people with lower income status have higher cancer death rates than 
those with higher income (16). Women who are uninsured or low-income are less likely 
to receive possibly lifesaving recommended cancer screenings (35). Despite the CDC 
funded Breast and Cervical Cancer Early Detection Program that provides screening and 
diagnostic services for uninsured and low-income women, evidence shows limited 
success reaching the targeted population (37). 
Health Insurance and Cost-sharing 
Health insurance is critical to whether people get necessary medical care, when 
and where they get their care, and finally how healthy they are (38). Evidence shows that 
a lack of health insurance coverage is one of the reasons people skip care, particularly 
preventive screenings (3–14). For example, a study found that disparities in cancer 
screenings by health insurance status and type of insurance exist among U.S. adults (3). 
Other previous observational studies show strong associations between health insurance 
coverage and the receipt of mammography and pap tests (10–13,33). Also, some 
evidence exists that show cost-sharing reduces the use of recommended procedures such 
as preventive interventions and cancer screenings (15). 
ACA provisions: (A) Medicaid Expansion 
To reduce the number of the uninsured population and improve access to care 
among the low-income population, the ACA expanded the coverage of Medicaid to 
include the entire population aged 18-64 with income below 138% of federal poverty 
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line. States participation in Medicaid expansion became optional after the national 
federation of independent business vs Sebelius supreme court ruling in 2012 (39). The 
Medicaid expansion took effect for most states on January 2014. As of September 2018, 
34 states have adopted Medicaid expansion, 3 states are considering expansion, and 14 
states did not expand Medicaid (40). In 2013, the poor population had the highest level of 
un-insurance (41). As most uninsured population before the ACA were low-income, 
Medicaid coverage expansion has the potential to improve access for low-income 
population to high quality health care including mammography and Pap tests (41,42). In 
2016, there were 11 million individuals newly eligible in Medicaid as a result of the 
Medicaid expansion according to a report from Centers for Medicare & Medicaid 
Services (CMS) (43). 
ACA provisions: (B) Removing Cost-Sharing for preventive care Services 
To increase the use of preventive care services, the ACA required private insurers 
and Medicare to cover all preventive services recommended by US Preventive Services 
Task Force (USPSTF) with a rating of A (strongly recommended) or B (recommended) 
without any cost sharing. The policy became effective on September 23, 2010 for private 
health insurers and on January 2011 for Medicare. Medicaid was not required to cover 
preventive services without cost-sharing. However, in 2013, incentives were offered to 
state Medicaid to cover preventive services for adults with no cost sharing. 
1.2 PURPOSE AND SIGNIFICANCE OF THE STUDY 
Assessing the impact of the ACA’s provisions on health cost, health care 
utilization, and access is critical to provide timely feedback on this important health 
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reform, especially when uncertainty continuous to surround it at both the state and federal 
levels. The ACA contained several strategies aimed at reducing health cost and un-
insurance rate as well as increasing access to needed health care including cancer 
preventive screenings among low-income population. However, to date, there is limited 
evidence as to the effectiveness of the policy in improving the uptake of mammograms 
and Pap tests among women. 
Given the previously discussed advantages of mammography and Pap tests in 
reducing the risk of cancer mortality, the suboptimal screening rates, and the established 
association between health coverage and utilization, this study tried to assess the impact 
of the ACA on mammography and Pap test rates among women in general as well as 
low-income women in particular. The findings from this study will provide scientific 
evidence that will add to or confirm the existing body of knowledge on this topic and it 
will advance our understanding of the potentials of the Medicaid expansion and the 
removal of cost-sharing in improving the delivery of healthcare.
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 THEORETICAL FRAMEWORK 
Because mammograms and Pap tests are effective in identifying possible cancer 
cases and can help improve quality and length of life, women will demand these services. 
Real demand is when women’s desire to have good health is backed up by their ability 
and willingness to pay. In economics, the Demand Theory suggests that demand for 
health services (i.e. mammograms and pap tests) is a function of price paid for the 
services, prices of other complementary and substitute services and products, income of 
household, underlying preference structure, and risk-attitude (44). Preference structure 
and risk-attitudes may be modified by education, health insurance, health campaigns, 
marital status, smoking status, regular exercise, alcohol use, etc. The ACA provisions 
such as expanding Medicaid coverage and removing cost-sharing will affect variables 
from the demand function such as prices and health insurance status. 
When health care services are not purchased directly from providers but rather 
obtained at subsidized prices due to health insurance, the out-of-pocket prices faced by 
consumers are typically much lower than the market price. This distinction is often 
described under "ex-post moral hazard". In this case, moral hazard is considered an 
efficient tool in increasing demand for preventive care that results in reduced future cost. 
The term “Moral Hazard” was first introduced into the modern academic literature by 
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Kenneth J Arrow in 1963 when he defined moral hazard in health insurance as the idea 
that “medical insurance increases the demand for medical care” (45). The notion of moral 
hazard was highlighted in the landmark RAND Health Insurance Experiment (RAND 
HIE) conducted between 1974-1977 (14). The RAND experiment randomly assigned a 
representative sample of families with adults under the age of 62 to health insurance 
plans with different levels of cost sharing, ranging from full coverage (zero cost sharing) 
to plans that provided almost no coverage. The experiment showed that when faced with 
cost-sharing, people reduce the use of all types of health care services particularly 
preventive care. Before the RAND experiment, the general idea was that health care 
utilization is affected only by health need. The experiment proved that seeking health is 
sensitive to price and therefore obtaining health insurance increase demand for health 
care. 
Mammography and Pap tests receipt were shown in a number of observational 
studies to be associated with health insurance coverage (10–13,33). For example, a study 
found that women without private insurance are less likely than women with private 
insurance to obtain high-quality mammography screening (46). Another study found that 
women who are uninsured are less likely to receive possibly lifesaving recommended 
cancer screenings (35). A study examined the role of health insurance on pap test and 
mammography utilization among immigrant and nonimmigrant women and found that 
women took the screenings as long as they had health insurance or a regular source of 
care (10). Another study used longitudinal survey data to examine the effect of insurance 
coverage on the rates of mammography and pap testing, and found that the rates 
decreased with an increasing occurrences of un-insurance (11). Preventive services 
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utilization was found to be associated with having health insurance, as insurance 
coverage increased the receipt of mammography and pap test increased (12). A study 
examined the effect of Medicaid expansion of 1996 on taking pap smear test, and found 
that previously uninsured women took the test after becoming eligible (13).  
2.2 MEDICAID EXPANSION   
Evidence from Pre-ACA 
In 2006, the state of Massachusetts passed a health care reform law that contained 
Medicaid expansion and subsidized private health insurance. The components of this 
legislation have been considered by many to serve as the blueprint for the ACA of 2010. 
Several quasi-experimental studies found the Massachusetts health reform to be 
associated with improved access and utilization of health care services among adults in 
general (47–49) and low-income population in particular (50–52). A study on the 
Massachusetts reform, anticipated large increases in coverage rates and access to care for 
low-income childless adults in the states expanding Medicaid under the ACA (50).  
In 2008, in the state of Oregon, a group of uninsured low-income adults were 
selected randomly by lottery to enroll for the Medicaid program. This created a chance to 
conduct a randomized control trial (RCT) that would examine the impact of expanding 
health coverage on access, utilization, and health outcomes among poor population. The 
Oregon Health Insurance Experiment (OHIE) showed increased health services use 
including mammography and pap tests (53). Another study took advantage of the 
randomized controlled trial setting to investigate the impact of the coverage expansion on 
cancer preventive screenings and found that the Medicaid expansion provided access to 
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important care and screenings that could help to detect cancers earlier especially among 
women (54). 
Evidence from Post-ACA 
Overall, 20 million uninsured adults gained insurance under the ACA (55). 11 
million were newly eligible in Medicaid as a result of the Medicaid coverage expansion 
(43). In 2016, Medicaid enrollment increased by 36% from 2014 among the states that 
had expanded Medicaid, compared with less than 12% in the non-expansion states (56). 
The reduction in un-insurance rate was larger in expansion states compared to non-
expansion states (57). Low-income population, the group targeted by the policy, 
experienced coverage rate increases (58–60). A recent study found that low-income 
population who have previously lacked coverage, experienced increased coverage by a 
7.5 percent in the sates that expanded Medicaid (60). In addition to improvements in 
coverage rate, improvements have been observed in health care access, utilization, 
affordability, and preventive care following the 2014 Medicaid expansion (61–69). 
However, some studies found no significant impact of the expansion on some certain 
outcomes such as length-of-stay, mortality, self-reported health, and doctor visits (57,70–
72). In subgroup analysis, early findings of the ACA indicate that there has been 
significant impact among the poor, low-educated adults, those living in rural areas, and 
racial and ethnic minorities live in Medicaid expansion states (41,73–78). However, a 
study suggests that large gaps remain in access and affordability, particularly for low-
income adults (79). Disparities in cancer screening by race and socioeconomic status may 
widen as women remain uninsured in non-expansion states and others gain coverage 
(80,81). As for mammography and pap tests, early post-ACA evidence gave mixed 
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results, particularly among low-income adults. Cole et al. (82) compared changes among 
federally funded community health centers in expansion versus non-expansion states 
from 2011 to 2014. Those centers were likely to be particularly affected by this 
expansion because many of their patients were uninsured and low income. Their study 
results found that, compared to centers in non-expansion states, centers in expansion 
states had significant improvements in for pap tests use (82). However, other studies did 
not find significant improvement from the Medicaid expansion on mammography and 
pap tests. For example, Simon et al. (83) examined data of low-income adults from 2010 
to 2015 and found that the expansion increased access to certain types of preventive care 
but no significant impact was found on mammography and pap tests (83). Miller et al. 
(57) looked at the first two years of the expansion and found no significant changes in the 
rates of mammography. A recent study by Cawley et al. (84) observed the impact of 
Medicaid expansion three years after the expansion and found no detectable impact on 
pap tests or mammograms. 
2.3 REMOVAL OF COST-SHARING 
The removal of cost-sharing for recommended preventive care services was 
believed to increase the use of those services. Evidence exists that show cost-sharing 
reduces the use of recommended procedures such as preventive interventions and cancer 
screenings (15). A study used data from 1995 to 2003 to examined the cost-sharing 
waiver on elderly women, anticipated that eliminating cost-sharing under the ACA may 
be an effective strategy for increasing preventive services use (85). Post-ACA, studies 
reported mixed results on the impact of removing cost-sharing on mammography and pap 
test (85–94). Hong et al. (94) evaluated the impact of removing cost-sharing in being up-
12 
to-date on mammography and Pap tests and found decreased rates of being up-to-date on 
women’s cancer screening among those with private insurance. Other studies examined 
the initial impact of the policy on privately insured women and found no change in 
mammography and Pap tests after the ACA (88–90). Other studies, however, yielded 
positive results. For example, a recent study found the policy to be associated with 
improved mammography and Pap tests among Hispanics and African Americans (95). 
Also, a study that assessed the policy from a health system level found that removing 
cost-sharing under the ACA to be associated with increased screening volumes among 
women age 50-74 (93). Studies that looked at Medicare population gave mixed results 
regarding mammography utilization. For example, Jensen et al (92) found minimal 
change in mammography among older women, while other studies found a statistically 
significant increase in mammography uptake after the ACA among elderly women 
(86,87).  
After this extensive literature review, it remains uncertain what would be the 
impact of the health coverage expansion through Medicaid and the removal of cost-
sharing on mammograms and Pap tests. Based on the demand theory in economics, I 
hypothesized that Medicaid coverage expansion and the removal of cost-sharing when 
using preventive services will be associated with improved rates of mammograms and 
Pap tests. 
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CHAPTER 3 
METHODS 
  
3.1 DATA SOURCE 
Data for this study was obtained from the Medical Expenditure Panel Survey - 
Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys of 
families and individuals, their medical providers (doctors, hospitals, pharmacies, etc.), 
and employers across the United States. MEPS collects data on the specific health 
services that Americans use, how frequently they use them, the cost of these services, and 
how they are paid for, as well as data on the cost, scope, and breadth of health insurance 
held by and available to U.S. workers. This study utilizes the Household 
Component (HC) of the MEPS, which collects data from a sample of families and 
individuals in selected communities across the United States, drawn from a nationally 
representative subsample of households that participated in the prior year's National 
Health Interview Survey (conducted by the National Center for Health Statistics). During 
the household interviews, MEPS collects detailed information for each person in the 
household on the following: demographic characteristics, health conditions, health status, 
use of medical services, charges and source of payments, access to care, satisfaction with 
care, health insurance coverage, income, and employment. MEPS contains the data on 
health care utilization, health insurance status, coverage source, and cost that are required 
to answer the research question. 
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3.2  DESIGN 
Difference-in-Differences design (Medicaid expansion study) 
This analytic design tests a comparison of the change in trends of outcomes 
before and after Medicaid expansion across expansion states vs non-expansion states, 
controlling for other covariates representing risk attitudes and preference structure. The 
treatment group includes women living in Medicaid expansion states and control group 
includes women living in non-expansion states. Only the states that expanded Medicaid 
between January 2014 and January 2016 were included in the treatment group (appendix 
A).  The states that already provided Medicaid or similar coverage to low-income adults 
before 2014 were excluded (District of Columbia, Delaware, Massachusetts, New York, 
and Vermont) (see appendix A). For estimating the DID parameters, pre-ACA period is 
defined as the years 2012-13 and the post period is defined as the years 2015-16.   
The following multivariate linear regression was estimated to find the effect of the 
policy change on the outcome variables, the likelihood of receiving mammography and 
pap smears: 
Yist = β0 + β1 Treatment + β2 Post + β3 (Treatment*Post) + βx Covariates + Ɛ 
Where “Yist” represents outcome for individual “i” living in state “s” at time ‘t”. 
β0 is the baseline average. The term “Treatment” is a dummy variable equal to 1 if the 
individual resides in a treatment group (expansion state). β1 is the difference between the 
two groups pre-intervention. The term “Post” is a dummy variable equal to 1 if the time 
is after the Medicaid expansion. β2 is the time trend in control group. The term 
“Treatment*Post” is an interaction term of intervention and time, β3 represents the 
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difference-in-differences estimator capturing the effect of Medicaid expansion. 
Covariates are added to the model to control for preference structure and risk attitudes. 
This regression model, in theory, will be able to indicate the effect of treatment if 
the intervention and control groups are identical at the baseline or show similar pattern of 
change over the years. In the real world, the intervention and control groups in pre-
intervention period are never identical and therefore differences between the groups need 
to be explicitly considered and incorporated in the analysis. The effect of program change 
can be estimated if the assumption of similar pattern of changes over the years in pre-
intervention years may be assumed in post-intervention periods as well. This is known as 
the “parallel assumption” in DID analysis. Since the parallel assumption must hold for an 
unbiased DID estimator, we can test the parallel movements or trend in the outcomes 
prior to policy change in treatment and control groups over a number of years. To assess 
the validity of this assumption, we regressed each outcome for the years 2005 to 2013 on 
variables indicating years, state expansion status and an interaction term of year and state 
expansion status. If the coefficient of the interaction term is not statistically different 
from zero, it implies that the rate of change of the dependent variables is not different 
between the intervention and control areas confirming the parallel movement of the 
outcome over the years prior to the implementation of the intervention. 
Counter-factual design (Cost-sharing study)  
We used a counterfactual analysis to determine the impact of ACA on the 
preventive screenings rate. Counterfactual analysis helps to understand what would have 
happened in post-ACA year if ACA was not there. This was done by estimating a model 
that examines determinants of the dependent variable for pre-ACA (year 2009). Then, the 
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estimated model was used to predict the dependent variable using post-ACA 
characteristics of individuals (the determinants from the model) (year 2016). The model 
basically works as pseudo control group allowing estimation of the utilization of 
screenings if ACA policy changes were absent. Effect of ACA is then estimated as: rate 
of dependent variable post-ACA minus the predicted rate of dependent variable in the 
same post-ACA year using counterfactual (that there was no ACA in that year). We 
chose determinants that we believe may modify the demand for the screening tests and 
the potential variables incorporated in the model are: age, race, income, education, 
marital status, region, health insurance type, physical activity, smoking status, 
comorbidity, routine medical checkup, metropolitan area, out-of-pocket expenses, and the 
availability of a usual source of care. It is important to note that there are few 
determinants of cancer screenings are likely to change due to the introduction of ACA, 
implying that incorporating these variables for the post-ACA sample to define the 
counterfactual will underestimate the effect of ACA because some of these determinants 
that are affected by ACA will pick-up some of the changes happened due to the 
implementation of ACA. Most important variables likely to change due to the 
implementation of ACA are coverage rate of health insurance and types of insurance 
people have. To ensure that the counterfactual estimates are not biased, insurance type 
and coverage rates should be kept the same in the post-ACA year as it was in the pre-
ACA year. This was done through adjusting the sampling weights so that pre- and post-
ACA insurance coverage and types of insurance coverage are the same. 
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3.3 OUTCOME 
The outcomes are the self-reported receipt of mammogram and Pap tests. For 
each preventive service, respondents were asked “About how long has it been since you 
had this mammogram/Pap test?” with possible responses being “within past year,” 
“within past 2 years,” etc. In accordance with screening guidelines, a dummy variable 
was created for mammogram utilization equal to 1 if the test was taken within 1 to 2 
years, and a dummy variable for pap test utilization equals to 1 if the test was taken 
within 1 to 3 years. 
We controlled for variables that we believe may modify the preference structure 
and risk attitude of women in the sample. According to the Demand Theory, demand for 
health services is a function of prices of the services, household income, preference 
structure, and risk-attitude. We chose covariates that may modify the preference structure 
and risk attitude, making individuals more risk averse and therefore more likely to 
undergo screening tests. The covariates chosen are: age, race, marital status, education, 
health insurance status, comorbidity, physical activity, smoking status, and metropolitan 
area (Table 3.1). 
3.4 SAMPLE 
Medicaid expansion sample 
Figure 3.1 shows the inclusion and exclusion criteria for the study samples that 
assessed the impact of the Medicaid expansion. From the 2012-16 MEPS datasets, the 
sample extracted consists of nonelderly low-income women living in the U.S. Women 
living in states that already provided Medicaid or similar coverage to low-income adults 
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before ACA’s Medicaid expansion in 2014 were excluded from the analysis (District of 
Columbia, Delaware, Massachusetts, New York, and Vermont). Women aged 65 years or 
older were excluded because they are eligible for Medicare. Women belonging to low-
income households, as defined by the ACA, were selected for the analysis as this group is 
eligible for participation in Medicaid after the policy change, if they were not enrolled in 
Medicaid at the time of expansion. In accordance with screening guidelines, the 
mammography cohort will include women aged 40-64 and the Pap test cohort will 
include women aged 21-64. Women with concurrent or past diagnoses with breast or 
cervical cancer were excluded from the analysis to focus on utilization of screening 
services for preventive or early diagnosis purposes (Figure 3.1). 
Cost-sharing sample 
Figure 3.2 shows the inclusion and exclusion criteria for the study samples that 
assessed the impact the removal of cost-sharing for preventive care services. From the 
MEPS 2009 and 2016 data set, there were two separate cohorts for mammography and 
pap test. In accordance with the USPSTF screening guidelines, the mammography cohort 
will include women aged 40 and older and the pap test cohort will include women aged 
21-65. Although the recent USPSTF guidelines regarding breast cancer recommends 
mammography for women aged 50-74 every 2 years, our mammography cohort included 
women aged 40 and older because the ACA still utilizes the 2002 guidelines. Women 
with concurrent or past diagnoses with breast or cervical cancer were excluded from the 
analysis to focus on screening for preventive purposes (Figure 3.2). 
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3.5 STATISTICAL ANALYSIS 
Difference-in-Differences analysis 
First, univariate analysis was done to produce baseline descriptive statistics of the 
low-income women living in treatment (expansion states) and control groups (non-
expansion states). Second, we tested the parallel trends assumption across expansion and 
non-expansion states by regressing each outcome for the years 2005 to 2013 on variables 
indicating years, state expansion status and an interaction term of year and state 
expansion status. Third, a difference-in-differences regression model was estimated by 
linear ordinary least squares. A linear model was chosen to allow a direct interpretation 
of the coefficients and avoid interpretive issues inherent to interaction terms in nonlinear 
models (97,98). The key parameter of interest from the DID model was the parameter 
associated with the interaction between treatment and time. This parameter represents the 
estimated difference in outcome rates between pre- and post-policy change, across states 
that were and were not affected by the policy change. Differences were considered 
statistically significant if P-value of t-statistics <0.05. Finally, a sub-group analyses was 
done using linear regression and univariate analysis to explain the effect of different 
demographics, socioeconomics, and geographic determinants on screening use. All 
analyses were carried out using STATA software version 14 (2015; Stata 14.0 Statistical 
Software, College Station, TX, USA). The analyses accounted for probability weighting 
in the MEPS (99,100) to obtain national estimates of effects of the policy change. 
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Counter-factual analysis 
Univariate analyses will be done to produce descriptive statistics of women’s 
characteristics before and after the implementation of ACA in the sample. The main 
statistical modeling will be based on a regression equation explaining the variability of 
the dependent variables in pre-ACA period using a number of determinants or 
explanatory variables. The equations estimated can be written as: 
𝑌𝑖0 =  𝛽0 + ∑ 𝛽𝑗𝑋𝑖𝑗0, where Yio is the value of dependent variable for individual i 
for the pre-ACA year 0 and [Xj] is a set of potential determinants of Y. This estimated 
model was then used to predict the dependent variable for the post-ACA years using the 
values of determinants in the post-ACA data set. In other words, we have predicted the 
values of Y for the post-ACA year t using the estimates of b from the pre-ACA year.  
𝑌𝑖𝑡 =  𝛽0̂ + ∑ 𝛽?̂?𝑋𝑖𝑗𝑡 
The estimated coefficients b obtained for pre-ACA year will be used to predict the 
values of dependent variable for individuals in post-ACA year, the year t. Another 
regression model was estimated to predict the values of Y in post-ACA year using post-
ACA data.  The effect of ACA will be estimated as the value of dependent variable in the 
post-ACA year minus the predicted value of the dependent variable in the post-ACA year 
using the regression model obtained using pre-ACA year (the counterfactual). A positive 
difference means that women in post-ACA used more mammography and pap tests 
compared to pre-ACA year given various determinants of the dependent variable. Since a 
number of potential determinants of dependent variable may be affected by the 
introduction of ACA-triggered changes, these variables should be kept constant at the 
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pre-ACA level. These variables are related with insurance coverage and types of 
insurance under which the individuals are covered. We have kept the values of these 
determinants constant in relative terms at the pre-ACA level by changing the sampling 
weights proportionately. To assess the diagnostic/predictive accuracy of our logistic 
model, we used the area under the ROC curve measure. Third, we regressed the 
difference of the dependent variable, the estimated effect of ACA adoption, on some 
population characteristics to examine how different individual characteristics affect the 
outcome. Differences were considered statistically significant if P-value of the t-statistics 
<0.05. All statistical analysis will be carried out using STATA software version 14 
(2015; Stata 14.0 Statistical Software, College Station, TX, USA The analyses accounted 
for probability weighting in the MEPS (99,100). 
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Table 3.1 List of covariates (controls) 
Variable Categorization 
 
Age >= 18 (health costs cohort) 
21-64 (pap test cohort) 
>= 40 (mammogram cohort) 
Income Low 
Middle 
High 
Health Insurance type Any private 
Public only 
Uninsured 
Race White 
Black 
Other 
Education Some school 
High school 
College 
Marital status Married 
Widowed 
Divorced 
Separated 
Never Married 
Region Northeast 
Midwest 
South 
West 
Usual source of care Available  
Not available  
Physical activity Exercise frequently 
Does not exercise frequently 
Smoking status Smoker 
Non-smoker  
Comorbidity 0 chronic disease 
1 chronic disease 
2 chronic diseases or more 
Routine medical checkup Within last year 
More than a year ago 
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                  Figure 3.1 Inclusion and exclusion criteria (Medicaid expansion) 
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                        Figure 3.2 Inclusion and exclusion criteria (Cost-sharing) 
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CHAPTER 4 
MANUSCRIPT I 
 
THE IMPACT OF MEDICAID EXPANSION UNDER THE ACA ON 
MAMMOGRAPHY AND PAP TESTS AMONG LOW-INCOME 
WOMEN1 
 
Abstract 
Background: The ACA expanded the coverage of Medicaid to include entire population 
with income below 138% of federal poverty line which took effect on January 1, 2014. It 
remains unclear whether this policy change has improved access to and utilization of 
health care, particularly use of mammography and Pap tests among poor women. 
Methods: We used a difference-in-difference design to estimate the impact of Medicaid 
expansion under the ACA on mammography and Pap tests utilization among low-income 
women. In the DID model, expansion states are the treatment group and non-expansion 
states are the control group. The years 2012-13 are the pre-expansion period and 2015-16 
are the post-expansion period for the purpose of estimating the DID parameters. Results: 
The difference-in-difference estimate show that likelihood of utilizing mammograms did 
not change significantly among low-income women after the implementation of the 
Medicaid expansion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test 
decreased (coefficient -0.0615, t-statistics -2.76), and Medicaid enrollment has increased 
                                                          
1 Alharbi, A., Khan, M., Horner, R., Brandt, H., Chapman, Cole. To be submitted to American Journal of 
Preventive Medicine  
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significantly among low-income women living in expansion states (coefficient 0.0889 
with t-value of 3.68). Conclusion: Expansion of Medicaid was associated with increased 
Medicaid enrollment but did not yield near-term improvement in use of mammography 
and Pap tests among low-income women.  Factors beyond health insurance coverage may 
be important in determining the likelihood of obtaining these screening procedures and 
policy makers should try to identify other barriers to cancer screening services utilization 
among the low-income women in the USA. 
 
Introduction 
Breast cancer is the most commonly diagnosed cancer among American women, 
and the second most common cause of death from cancer besides lung cancer (101,102). 
Cervical cancer incidence rates declined by half between 1975 and 2014 due to the 
widespread uptake of the Pap test, but declines have slowed down in recent years 
(101,102). Evidence show that women who appropriately screen for breast and cervical 
cancer are likely to receive more timely diagnosis and treatment (16–21,25,26) and yet, 
rates of mammography and Pap test screenings remained suboptimal in the United States 
(103). Low-income women utilize less screenings than middle or high income women. In 
2015, 54.9% of low-income women received mammography while 60% received Pap test 
(103). The National Cancer Institute's goals include increasing the proportion of women 
who get regular mammograms to 80%, and similar goals have been issued for Pap tests. 
There are several possible reasons for the suboptimal screening rates, among which lack 
of health insurance coverage is considered an important one. There is evidence that health 
insurance is associated with uptake of mammogram and Pap test use (10–13,33).  
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The Patient Protection and Affordable Care Act of 2010 (ACA) expanded the 
coverage of Medicaid to include the entire population aged 18-64 with income below 
138% of the federal poverty line (104). Since uninsured adults were more likely to be 
low-income, Medicaid expansion has the potential to improve access to health care 
among this poor segment of the population (105–107). Under ACA, participation of 
States in Medicaid expansion became optional after a supreme court ruling in 2012 (39) 
but many states decided to participate in Medicaid expansion immediately after the policy 
change and by September 2015, majority of the states have expanded Medicaid. As of 
September 2018, 34 states have adopted Medicaid expansion, 3 states are considering 
expanding, and 14 states did not expand. Appendix A lists the states with Medicaid 
expansion status as of September 2018 (40). 
Previous evidence gave mixed results regarding the impact of Medicaid expansion 
on utilization of mammography and Pap tests (108–111). Since no conclusive evidence is 
available, this study made an attempt to understand the effect of Medicaid expansion on 
probability of obtaining screening tests like mammography and Pap tests among low-
income women. Since the study is using nationally representative data set, the results 
would indicate the effects of policy change for the country as a whole. Nationally 
representative data will also allow identification of factor affecting utilization rates. 
Methods 
Data source 
Data for this study was obtained from the Medical Expenditure Panel Survey - 
Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys which 
collects data from a sample of families and individuals in selected communities across 
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the United States, drawn from a nationally representative subsample of households. The 
MEPS contains the data on health care utilization, health insurance status, and coverage 
source that are required to answer the research question. The combined average response 
rate for the years 2012-2016 was 50.7% (112). 
Sample 
From the 2012-16 MEPS datasets, the sample extracted consists of nonelderly 
low-income women living in the U.S. Women living in states that already provided 
Medicaid or similar coverage to low-income adults before ACA’s Medicaid expansion in 
2014 were excluded from the analysis (District of Columbia, Delaware, Massachusetts, 
New York, and Vermont). Women aged 65 years or older were excluded because they are 
eligible for Medicare. Women belonging to low-income households, as defined by the 
ACA, were selected for the analysis as this group is eligible for participation in Medicaid 
after the policy change, if they were not enrolled in Medicaid at the time of expansion. In 
accordance with screening guidelines, the mammography cohort will include women 
aged 40-64 and the Pap test cohort will include women aged 21-64. Women with 
concurrent or past diagnoses with breast or cervical cancer were excluded from the 
analysis to focus on utilization of screening services for preventive or early diagnosis 
purposes. 
Design 
This study used a difference-in-difference (DID) design in a regression 
framework. This analytic design tests a comparison of the change in trends of outcomes 
before and after Medicaid expansion across expansion states vs non-expansion states, 
controlling for other covariates representing risk attitudes and preference structure. The 
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treatment group includes women living in Medicaid expansion states and control group 
includes women living in non-expansion states. Only the states that expanded Medicaid 
between January 2014 and January 2016 were included in the treatment group (appendix 
A).  The states that already provided Medicaid or similar coverage to low-income adults 
before 2014 were excluded (District of Columbia, Delaware, Massachusetts, New York, 
and Vermont) (see appendix A). For estimating the DID parameters, pre-ACA period is 
defined as the years 2012-13 and the post period is defined as the years 2015-16.   
The following multivariate linear regression was estimated to find the effect of the 
policy change on the outcome variables, the likelihood of receiving mammography and 
pap smears: 
Yist = β0 + β1 Treatment + β2 Post + β3 (Treatment*Post) + βx Covariates + Ɛ 
Where “Yist” represents outcome for individual “i” living in state “s” at time ‘t”. 
β0 is the baseline average. The term “Treatment” is a dummy variable equal to 1 if the 
individual resides in a treatment group (expansion state). β1 is the difference between the 
two groups pre-intervention. The term “Post” is a dummy variable equal to 1 if the time 
is after the Medicaid expansion. β2 is the time trend in control group. The term 
“Treatment*Post” is an interaction term of intervention and time, β3 represents the 
difference-in-differences estimator capturing the effect of Medicaid expansion. 
Covariates are added to the model to control for preference structure and risk attitudes. 
This regression model, in theory, will be able to indicate the effect of treatment if 
the intervention and control groups are identical at the baseline or show similar pattern of 
change over the years. In the real world, the intervention and control groups in pre-
intervention period are never identical and therefore differences between the groups need 
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to be explicitly considered and incorporated in the analysis. The effect of program change 
can be estimated if the assumption of similar pattern of changes over the years in pre-
intervention years may be assumed in post-intervention periods as well. This is known as 
the “parallel assumption” in DID analysis. Since the parallel assumption must hold for an 
unbiased DID estimator, we can test the parallel movements or trend in the outcomes 
prior to policy change in treatment and control groups over a number of years. To assess 
the validity of this assumption, we regressed each outcome for the years 2005 to 2013 on 
variables indicating years, state expansion status and an interaction term of year and state 
expansion status. If the coefficient of the interaction term is not statistically different 
from zero, it implies that the rate of change of the dependent variables is not different 
between the intervention and control areas confirming the parallel movement of the 
outcome over the years prior to the implementation of the intervention. 
Outcome 
The outcomes for this study are the self-reported receipt of mammogram, Pap test, 
and Medicaid enrollment status. For the preventive services, respondents were asked 
“About how long has it been since you had this mammogram/Pap test?” with possible 
responses being “within past year,” “within past 2 years,” etc. In accordance with 
screening guidelines, a dummy variable was created for mammogram utilization equal to 
1 if the test was taken within 1 to 2 years, and a dummy variable for pap test utilization 
equals to 1 if the test was taken within 1 to 3 years. 
Covariates 
We controlled for variables that we believe may modify the preference structure 
and risk attitude of women in the sample. According to the Demand Theory, demand for 
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health services is a function of prices of the services, household income, preference 
structure, and risk-attitude. We chose covariates that may modify the preference structure 
and risk attitude, making individuals more risk averse and therefore more likely to 
undergo screening tests. The covariates chosen are: age, race, marital status, education, 
health insurance status, comorbidity, physical activity, smoking status, and metropolitan 
area. 
Statistical analysis 
First, univariate analysis was done to produce baseline descriptive statistics of the 
low-income women living in treatment (expansion states) and control groups (non-
expansion states). Second, we tested the parallel trends assumption across expansion and 
non-expansion states by regressing each outcome for the years 2005 to 2013 on variables 
indicating years, state expansion status and an interaction term of year and state 
expansion status. Third, a difference-in-differences regression model was estimated by 
linear ordinary least squares. A linear model was chosen to allow a direct interpretation 
of the coefficients and avoid interpretive issues inherent to interaction terms in nonlinear 
models (97,98). The key parameter of interest from the DID model was the parameter 
associated with the interaction between treatment and time. This parameter represents the 
estimated difference in outcome rates between pre- and post-policy change, across states 
that were and were not affected by the policy change. Differences were considered 
statistically significant if P-value of t-statistics <0.05. Finally, a sub-group analyses was 
done using linear regression and univariate analysis to explain the effect of different 
demographics, socioeconomics, and geographic determinants on screening use. All 
analyses were carried out using STATA software version 14 (2015; Stata 14.0 Statistical 
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Software, College Station, TX, USA). The analyses accounted for probability weighting 
in the MEPS (99,100) to obtain national estimates of effects of the policy change. 
Results 
Table 4.1 shows the baseline characteristics of the nonelderly low-income women 
living in expansion and non-expansion states. Majority of the low-income women were 
white in both expansion and non-expansion states, however, more black women lived in 
non-expansion states (37.38%) compared to expansion states (23.94%). In both treatment 
and control groups, majority of low-income women did not have a college degree (Table 
4.1). In expansion and non-expansion states, majority of low-income women had public 
health insurance, however, more women had public health insurance in expansion states 
(53.22%) as compared to non-expansion states (41.67%). Majority of the low-income 
women lived in metropolitan areas in both treatment and control groups (Table 4.1). 
Women in treatment and control groups had a similar age mean (37). Therefore, states 
deciding to expand Medicaid were different from the states deciding not to expand in 
terms of percent of low income population not white, level of coverage of public 
insurance program and percent of poor women living in metro areas. 
Figure 4.1 shows trends in mammogram and Pap tests rates across expansion and 
non-expansion state for the years 2005 to 2013. Results from the regression that tested 
the parallel assumption of the time trend of outcome variable show that the slope of the 
trend functions were similar for these two groups of states prior to the implementation of 
the ACA policy on Medicaid expansion (Appendix B). 
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Table 4.2 reports the results from the univariate analysis that examined screening 
rates among women living in expansion states post-ACA by different sub-groups. The 
results show majority of low-income women who used mammograms and Pap tests were 
high-income (76.20%, 85.73%) high-educated (72.93%, 83.88%), Black (73.61%, 
87.91%), with private insurance (74.20%, 84.13%), living in metropolitan areas (71.36%, 
83.13%), and reported having a usual source of care (74.52%, 83.92%), for 
mammograms and Pap tests respectively. 
Table 4.3 reports the results from the difference-in-difference adjusted regression 
model. The DID estimates indicate that the probability of enrolling to Medicaid has 
increased significantly among the low-income women after the implementation of 
Medicaid expansion (estimated coefficient 0.0889 with t-value 3.68). The DID estimates 
indicate that the probability of utilizing mammograms did not change significantly 
among low-income women after the implementation of the Medicaid expansion 
(estimated coefficient -0.0476 with t-value -1.26). For the Pap tests, the DID estimate 
indicate that the probability of utilizing the test has decreased significantly among low-
income women after the implementation of the Medicaid expansion compared to non-
expansion states (estimated coefficient -0.0615, t-value -2.76). 
Table 4.4 shows the results on the likelihood of receiving mammograms and Pap 
tests among low-income women using a number of possible determinants of utilization of 
the screening tests. The sub-group analysis shows that poor women with higher age were 
more likely to receive mammograms (estimated coefficient 0.0102, t-value 4.16) and less 
likely to receive Pap tests (estimated coefficient -0.174, t-value -5.08). Black women 
were more likely to receive mammograms (estimated coefficient 0.0812, t-value 3.87) 
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and Pap tests (estimated coefficient 0.0686, t-value 5.75) as compared to white women. 
The table also indicates that women from other minority population groups were less 
likely to receive Pap tests as compared to white women (estimated coefficient -0.0646, t-
value -2.90). Women with a college degree were more likely to receive mammograms 
(estimated coefficient 0.0605, t-value 2.56) and women who were divorced were less 
likely to receive mammograms (coefficient -0.0875, t-value -3.47) and Pap tests 
(coefficient -0.0385, t-value -2.00) compared to married women. Women with public 
health insurance were less likely than those with private insurance to receive 
mammograms (estimated coefficient -0.0654, t-value -2.55) but no difference was 
detected for Pap test use (estimated coefficient -0.00391, t-value -0.26). Uninsured 
women were less likely to receive mammograms (estimated coefficient -0.250, t-value -
8.97) and Pap tests (estimated coefficient -0.110, t-value -6.61). Women living in non-
metropolitan areas were less likely than those in metropolitan areas to receive Pap tests 
(estimated coefficient -0.0615, t-value -3.41) but no difference was detected for 
mammogram use (estimated coefficient -0.0489, t-value -1.62). Women who reported not 
having a usual source of care were less likely to receive mammograms (estimated 
coefficient -0.141, t-value -4.03) and Pap tests (estimated coefficient -0.0562, t-value -
3.02) compared to those who have a usual source of care. Non-smokers were more likely 
to receive mammograms (estimated coefficient 0.0706, t-value 3.15) and Pap tests 
(estimated coefficient 0.0446, t-value 3.30) as compared to smokers. Women with two or 
more chronic diseases were more likely to receive mammograms (estimated coefficient 
0.133, t-value 5.22) but no differences were detected for Pap test use (estimated 
coefficient 0.0251, t-value 1.58). 
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Discussion  
The affordable care act (ACA) expanded Medicaid eligibility coverage to the 
entire low-income population in order to improve access and utilization among this 
disadvantage section of the population. In the years before the ACA, rates of 
mammograms and Pap tests showed declining trends among women and more so among 
poor women (103). This study examined the impact of expanding health coverage 
through Medicaid on the rates of mammograms and Pap tests among poor women. The 
difference-in-difference (DID) estimates indicate that Medicaid enrollment has increased 
significantly among low-income women after the implementation of the Medicaid 
expansion (see Table 4.3). This is a proximate measure of success of ACA in terms of 
providing coverage to poor women through Medicaid. Other studies also found increased 
Medicaid enrollment in expansion states compared to non-expansion states (113). 
However, the increase in Medicaid enrollment among low-income women did not 
translate into increased rates of mammograms or Pap test utilization. Other studies also 
found little impact of Medicaid expansion on mammography and Pap tests rates 
(84,113,114). 
Although the difference-in-differences estimate did not show increase in 
mammograms and Pap tests rates, low-income women living in expansion states used 
more screenings than their counterparts in non-expansion states (Table 4.3). Historically, 
mortality rates of breast and cervical cancer were lower in the states that elected to 
expand Medicaid compared to those who elected not to expand (115). We compared 
cancer burden in expansion vs non-expansion states in pre and post-ACA using data from 
the National Cancer Institute (NCI) and found that women in expansion states had lower 
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mortality rates compared to women in non-expansion states (breast cancer: 20.13 vs 
20.50; and cervical cancer: 1.97 vs 2.41) per 100,000 resident (115). A previous study 
found that Southeastern states without Medicaid expansion tended to have higher cancer 
and lower screening rates and therefore disparities in cancer screening that already 
disfavor states with high cancer rates may widen in states that have chosen not to expand 
Medicaid (116). 
A number of possible explanations can be advanced for this lack of improvements 
in mammograms and Pap tests rates among the low-income women despite gaining 
insurance coverage through Medicaid. First, our analysis show that low-income women 
with private insurance were more likely to receive mammograms than those with public 
insurance (Table 4.4). Also, in expansion states, the proportion of low-income women 
with private insurance used more mammograms and Pap tests than those with public 
insurance (Table 4.2). Another study also found that women with employer-based 
insurance/Medicare were more likely to get breast and cervical cancer screenings (117). 
According to a survey conducted by the National Center for Health Statistics, only two 
out of three primary care physicians surveyed in 2011 were willing to accept new 
Medicaid patients (118). Our analysis showed that women who reported having a usual 
source of care were more likely to receive mammograms and Pap tests than those without 
a usual source of care (Table 4.4). In expansion states, the proportion of low-income 
women who have a usual source of care used more mammograms and Pap tests than their 
counterparts (Table 4.2). Therefore, the type of insurance and the availability of a usual 
source of care may have the most effect on access and receiving theses screenings. 
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Second, there are previous studies that found that Medicaid expansion was 
effective in improving rates of certain preventive services such as glucose testing, 
cholesterol testing, and annual check-up, but not for cancer screenings (108,109). This is 
probably because mammograms and Pap tests come with side effects that may discourage 
women in accepting the tests (119–122). Mammograms show relative high false 
positivity which creates significant loss of wellbeing and quality of life including pain 
and suffering, anxiety, and other side effects. Similar to mammograms, Pap tests may 
come with harm when abnormal results lead to vaginal bleeding, pain, infection, and 
anxiety. Physicians make trade-offs between benefits and risks when making 
recommendations about who should be screened (123). Also, the guidelines for 
mammograms and Pap tests were updated around the time of the ACA’s provisions. The 
guidelines for mammograms were updated in 2009 to recommend mammograms for 
women aged 50-75 every 2 years from the previous guidelines that recommended 
screening every 1-2 years for women aged 40 or older (124). The guidelines for cervical 
cancer screenings was updated in 2012 to recommend the Pap test for women aged 21-65 
every three years from the previous guidelines that recommended screening annually for 
women who are sexually active. These guideline changes occurred around the same time 
as the expansion of Medicaid under ACA which may explain the overall decline in cancer 
screenings. However, the effect of changing the recommendation guidelines is universal 
across expansion and non-expansion states and therefore may not explain the lack of 
effect on mammograms and Pap tests in expansion states in our difference-in-difference 
design. 
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Third, the results from the difference-in-difference may have been biased or 
equalized because of the possibility that a significant number of poor women received 
screenings through other national programs such as the CDC’s National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP). The program was established in 
1990 to provide free and/or reduced cost mammograms and Pap tests to women with 
limited incomes and those who lack health insurance. Although number of women 
receiving those services through the NBCCEDP has decreased in 2015-16 compared to 
2013 (125), low-income women still benefit from this program which may have negated 
the impact of ACA on mammograms and Pap tests rates in our difference-differences 
analysis. Between 2012 and 2017 the NBCCEDP program provided 740,108 Pap tests 
and 902,751 mammograms to low-income women (125). In expansion states between 
2012 and 2017 there were 441,206 Pap test provided (452 screenings per 100,000 
woman) and 498,659 mammograms (511 screenings per 100,000 woman) while in non-
expansion states the rates were 398 per 100,000 woman for Pap test and 573 per 100,000 
woman for mammography (125). Mammograms provided to women in non-expansion 
states was about 12% higher than the rate in expansion states and the opposite is true for 
Pap tests (12% lower in non-expansion states). Such differences can potentially bias the 
estimation of the effect of ACA on the uptake of mammograms and Pap tests.  
Fourth, our analysis showed that the majority of screenings occurred among the 
high-income high-educated women while low-income women had the least utilization 
rates (Table 4.2). Before the ACA, a study found low-income women were less likely to 
receive possibly lifesaving recommended cancer screenings (35). A post-ACA study 
examined the impact of Medicaid expansion on disparities in cancer screenings and found 
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that large gaps remain in access, particularly for low-income adults (79). Our analysis 
showed that disparities in terms of using mammograms and Pap tests remained and may 
have actually become worse. This possibly implies that other factors beyond the 
insurance coverage provided through Medicaid should be examined in order to reduce 
socioeconomic disparities. 
Finally, our sub-group analyses helped shed light on the likelihood of receiving 
mammograms and Pap tests among low-income women using a number of possible 
determinants of utilization of the screening tests. As women got older they were more 
likely to receive mammograms and less likely to receive pap tests (Table 4.4). This is 
expected as evidence suggests benefits from mammograms are more evident for older 
women while benefits from Pap tests are more evident for younger women (126,127). 
Low-income women living in metropolitan areas were more likely to receive 
mammograms and Pap tests (Table 4.4). Also, in expansion states, the proportion of low-
income women living in metropolitan areas used more mammograms and Pap tests 
(Table 4.2). This is expected as metropolitan areas have more medical care providers than 
non-metro or rural areas. Black women were more likely than white women to receive a 
Pap test (Table 4.4). Also, in expansion states, the proportion of black women used more 
mammograms and Pap tests than white women (Table 4.2). Historically, black women in 
the U.S. are more likely to be diagnosed and die from breast and cervical cancer than 
white women, which may explain the increased use of the screenings (128).  
Conclusion  
Our study shows that expansion of Medicaid under the ACA was associated with 
increased Medicaid enrollment but did not yield near-term improvements in the use of 
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mammography and Pap tests among low-income women. Although the difference-in-
differences did not show improvements in mammograms and Pap tests due to Medicaid 
expansion under ACA, low-income women living in expansion states used higher level of 
screenings than their counterparts in non-expansion states. In DID, lack of any positive 
results is due to pattern of changes happened in screening rates in expansion and non-
expansion states. In expansion states, the increase in screening rates were either lower or 
negative. Since Medicaid expansion did not affect these screening tests, policy makers 
need to examine other factors that may act as barriers in improving access and utilization. 
Some possible explanations for this lack of impact of the Medicaid expansion on 
mammograms and Pap tests are presented in the discussion section but we have no 
concrete evidence to conclusively say which factors have affected access to screening 
tests adversely in the expansion states compared to non-expansion states. It is also 
possible that a longer timeframe will be needed for a change to be manifested but this 
study only looked at three years after the policy change. Future research on provider 
availability and characteristics, insurance types, and geographical variations is warranted 
for a better understanding of the use of cancer screening procedures by the poor women 
in the USA. 
We acknowledge some important limitations of this study. First, information 
about outcomes relied on self-reported survey responses which might be subject to recall 
error. However, the MEPS follow up with health providers to reduce the reporting errors 
but some errors may still remain, especially for procedures and tests requiring longer 
recall time frame. Second, the data used in the analysis are cross-sectional and 
comparison of cross-sectional data at different years is not same as observing changes in 
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the outcomes with the implementation of ACA. The study design made an attempt to 
tease-out the effect of policy changes through DID and in most cases DID approach can 
identify the effect of policy change even when the starting characteristics of the control 
and intervention groups are significantly different. Third, since repeated cross-sectional 
survey data were used, it was not possible to show the pathways of outcome variation, 
i.e., the effect of ACA on Medicaid enrollment and effect of Medicaid enrollment on the 
outcomes of interest. Fourth, this study examined the initial 3-year period after the ACA 
Medicaid expansion provision and a longer time frame may be needed to be able to see 
the effects of policy changes on outcomes. Finally, there were changes in the USPSTF 
guidelines for breast cancer and cervical screening that occurred around the same time as 
the ACA provisions which may have led to overall declines in cancer screening. In 2009 
the guidelines for breast cancer screenings was updated to recommend biennial screening 
instead of every 1-2 year screenings. Also, in 2012 the USPSTF guidelines for cervical 
cancer was updated to recommend the test every 3 years instead of every year. National 
programs providing these tests to poor women may have dampen the effect of the policy 
change and if the national program in post-policy change years provided more emphasis 
on covering screenings in non-expansion states, it can potentially offset any positive 
effects of Medicaid expansion when estimated through DID modeling. In any case, this 
lack of relative improvements in cancer screenings in the Medicaid expansion states 
(compared to non-expansion states) is perplexing and would require supplementing the 
national data with other program effects and other structural differences between these 
two groups of states. 
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Table 4.1 Baseline characteristics of low-income women aged 18-64, living in expansion 
and non-expansion states, pre-ACA (2012-13), MEPS dataset 
Characteristic Non-expansion 
states 
N= 3,729 
Expansion states 
N= 3,459 
P value  
Age 37 (mean) 37 (mean) 0.0839 
Race   0.000 
White 57.39 67.07  
Black 37.38 23.94  
Other minorities 5.23 8.99  
Education   0.000 
Some school 34.51 38.90  
High school 34.54 31.17  
College 30.95 29.94  
Health insurance   0.000 
Private 18.10 16.48  
Public 41.67 53.22  
Uninsured 40.23 30.30  
Metropolitan area   0.000 
Metro 82.38 87.80  
Non-metro 17.62 12.20  
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Table 4.2 Rates of mammograms and Pap tests use in different groups in expansion 
states, results univariate analysis (2012-16), MEPS dataset  
 
Table 4.3 Results from the difference-in-differences adjusted regression model, 
nonelderly low-income women (2012-16), MEPS dataset 
Outcome Expansion states 
 
Non-expansion states Difference-in-
differences 
Pre-ACA rate Post-ACA rate Pre-ACA rate Post-ACA rate 
Mammogram  
62.66 % 
 
64.69 % 
 
58.87 % 
 
61.77 % 
-0.0476 
(-1.26) 
Pap tests  
81.90 % 
 
80.19 % 
 
78.80 % 
 
79.36 % 
-0.0615** 
(-2.76) 
Medicaid 
enrollment 
 
38.10 % 
 
52.31 % 
 
21.12 % 
 
25.03 % 
0.0889*** 
(3.68) 
 
 
 Mammogram Pap test 
 
 % in post-ACA change P value % in post-ACA change P value 
 
Low-income 64.69 + 2.03 0.337 80.19 -1.71 0.151 
 
Middle-income  70.08 - 3.14 0.178 81.05 -0.71 0.633 
 
High-income 76.20 -3.1 0.094 85.73 -1.16 0.351 
 
White 70.10 -0.99 0.497 81.49 -0.97 0.289 
 
Black 73.61 -1.34 0.645 87.91 -.04 0.979 
 
Other  69.02 +1.22 0.715 79.77 -2.36 0.251 
 
Some school 65.23 +0.20 0.943 80.93 -0.56 0.760 
 
High school 69.24 +1.32 0.594 79.51 +0.33 0.832 
 
College  72.93 -2.31 0.150 83.88 -1.7 0.076 
 
Metro 71.36 -0.87 0.496 83.13 -0.96 0.213 
 
Nonmetro/rural 61.42 -2.12 0.610 73.33 -3.14 0.259 
 
Private insurance 74.20 -3.49 0.015 84.13 -1.99 0.30 
 
Public insurance 67.10 -4.03 0.122 80.86 -4.9 0.001 
 
Uninsured 52.87 +2.04 0.597 73.72 +0.93 0.706 
 
Available USC 74.52 -1.91 0.135 83.92 -2.08 0.012 
 
Not Available USC 48.96 +0.83 0.80 75.64 +0.47 0.793 
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Table 4.4 Likelihoods of receiving mammograms and Pap tests using a number of 
determinants, results from adjusted linear regression model (2012-16), MEPS dataset 
Determinants Mammogram Pap tests  
Age  
 
0.0102*** 
(4.16) 
0.000137 
(0.11) 
21-39 
 
 0 
(.) 
40-49 
 
0 
(.) 
-0.0789*** 
(-3.59) 
50-64 
 
-0.00818 
(-0.23) 
-0.174*** 
(-5.08) 
White 
 
0 
(.) 
0 
(.) 
Black 
 
0.0812*** 
(3.87) 
0.0686*** 
(5.75) 
Other minorities  
 
-0.0588 
(-1.59) 
-0.0646** 
(-2.90) 
Some school 
 
0 
(.) 
0 
(.) 
High school 
 
0.0419 
(1.82) 
-0.00437 
(-0.33) 
College 
 
0.0605* 
(2.56) 
-0.0120 
(-0.85) 
Married 
 
0 
(.) 
0 
(.) 
Widowed 
 
-0.103* 
(-2.56) 
-0.0883* 
(-2.47) 
Divorced 
 
-0.0875*** 
(-3.47) 
-0.0385* 
(-2.00) 
Separated 
 
-0.0799* 
(-2.37) 
-0.00593 
(-0.27) 
Never Married 
 
-0.0749** 
(-2.86) 
-0.0277* 
(-2.03) 
Private insurance 
 
0 
(.) 
0 
(.) 
Public insurance 
 
-0.0654* 
(-2.55) 
-0.00391 
(-0.26) 
Uninsured 
 
-0.250*** 
(-8.97) 
-0.110*** 
(-6.61) 
Metro area 
 
0 
(.) 
0 
(.) 
Non-metro area  
 
-0.0489 
(-1.62) 
-0.0615*** 
(-3.41) 
Usual source of care available 
 
0 
(.) 
0 
(.) 
Usual source of care not available -0.141*** 
(-4.03) 
-0.0562** 
(-3.02) 
Exercise regularly 
 
0 
(.) 
0 
(.) 
Do not exercise regularly 
 
-0.00171 
(-0.09) 
-0.0102 
(-0.92) 
Smoker 
 
0 
(.) 
0 
(.) 
Non-smoker 
 
0.0706** 
(3.15) 
0.0446*** 
(3.30) 
No chronic diseases  
 
0 
(.) 
0 
(.) 
1 chronic disease 
 
0.0479 
(1.68) 
0.0223 
(1.63) 
+2 chronic diseases  
 
0.133*** 
(5.22) 
0.0251 
(1.58) 
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Figure 4.1 Trends in mammogram and Pap across expansion and non-expansion states 
among low-income women, MEPS 2005-13 
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CHAPTER 5 
MANUSCRIPT II 
 
THE IMPACT OF REMOVING COST SHARING UNDER THE 
AFFORDABLE CARE ACT (ACA) ON MAMMOGRAPHY AND PAP 
TEST USE2 
 
Abstract 
Background: The ACA required private insurers and Medicare to cover preventive 
services recommended by the USPSTF without any cost sharing to improve utilization of 
these services. This study tried to identify the impact of removing cost sharing on 
mammography and pap test utilization rates. Methods: Counterfactual analysis was used 
to predict what would have been the screening rates in post-ACA if ACA was not there. 
This was done by estimating a model that examines determinants of dependent variable 
for the pre-ACA year (pre-ACA year is 2009). The estimated model was then used to 
predict the dependent variable for the post-ACA year using individual characteristics and 
other relevant variables unlikely to be affected by ACA (post-ACA year is 2016). Effect 
of ACA is defined as the difference between the  values of dependent variables in post-
ACA and the predicted values of dependent variables in the post-ACA year using 
counterfactual. Results: The counterfactual analysis show that the utilization of 
mammogram and pap test did not improve following the ACA. Conclusion: following 
                                                          
2 Alharbi, A., Khan, M., Horner, R., Brandt, H., Chapman, Cole. To be submitted to American Journal of 
Preventive Medicine 
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the removal of cost-sharing under the ACA, no improvement in mammography or pap 
tests rate was observed. It appears that financial barrier was not an important factor in 
affecting utilization of the screening tests and policy makers would have to focus on other 
non-financial barriers in order to improve coverage of the tests. 
Introduction 
Cancer is among the leading causes of death in the United States. An estimated 
41,400 deaths from invasive breast cancer and 4,170 deaths from cervical cancer will 
occur in 2018 (16). Mammography and pap test screenings allow early detection of the 
diseases leading to potentially successful treatment (17–20,26,129,130). Despite evidence 
of screening effectiveness in improving health outcomes, rates of mammography and pap 
test screenings remained suboptimal in the United States (103). The US Preventive 
Services Task Force (USPSTF) recommends mammography for women aged 50-74 years 
every two years, and pap test for women aged 21-65 years every three years (24). 
According to the Centers for Disease Control and Prevention (CDC), in 2015, 65.3% of 
women aged 40 years and older had a mammogram within previous two years, while 
69% of women aged 18 years had a pap test within three years (103). Suboptimal rates of 
screenings may have resulted from financial barriers women face such as cost-sharing, 
the amount of money individuals required to pay when seeking medical care. There is 
evidence that cost-sharing reduces the use of health services, particularly preventive 
services (15,131). 
The Patient Protection and Affordable Care Act (ACA) required private insurers 
and Medicare to cover the preventive services recommended by US Preventive Services 
Task Force (USPSTF) with a rating of A (strongly recommended) or B (recommended) 
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without cost sharing. The policy became effective on September 23, 2010 for private 
health insurers and on January 2011 for Medicare (132). The goal was to increase the use 
of preventive services and, in turn, reduce costly events from poorly or unmanaged 
chronic conditions. Previous research  reported mixed results regarding the impact of 
removing cost sharing on mammography and pap test utilization (85–94). As the effect of 
removing cost-sharing on mammography and pap test utilization are still unclear, this 
study aims to generate evidence on the impact of changes brought about by the ACA on 
mammography and pap tests rates. 
Methods 
Data 
Data for this study was obtained from the Medical Expenditure Panel Survey - 
Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys which 
collects data from a sample of families and individuals in selected communities across 
the United States, drawn from a nationally representative subsample of households. 
MEPS contains the data on health insurance status and coverage source, utilization, and 
cost that are required to answer the research question. The MEPS contains the data on 
health care utilization, health insurance status, coverage source, and cost that are required 
to answer the research question. The combined average response rate for the years 2009 
and 2016 was 51.6% (112). 
Sample 
Figure 5.1 shows the inclusion and exclusion criteria for the study samples that 
assessed the impact the removal of cost-sharing for preventive care services. From the 
MEPS 2009 and 2016 data set, there were two separate cohorts for mammography and 
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pap test. In accordance with the USPSTF screening guidelines, the mammography cohort 
will include women aged 40 and older and the pap test cohort will include women aged 
21-65. Although the recent USPSTF guidelines regarding breast cancer recommends 
mammography for women aged 50-74 every 2 years, our mammography cohort included 
women aged 40 and older because the ACA still utilizes the 2002 guidelines. Women 
with concurrent or past diagnoses with breast or cervical cancer were excluded from the 
analysis to focus on screening for preventive purposes (Figure 5.1). 
Design 
We used a counterfactual analysis to determine the impact of ACA on the 
preventive screenings rate. Counterfactual analysis helps to understand what would have 
happened in post-ACA year if ACA was not there. This was done by estimating a model 
that examines determinants of the dependent variable for pre-ACA (year 2009). Then, the 
estimated model was used to predict the dependent variable using post-ACA 
characteristics of individuals (the determinants from the model) (year 2016). The model 
basically works as pseudo control group allowing estimation of the utilization of 
screenings if ACA policy changes were absent. Effect of ACA is then estimated as: rate 
of dependent variable post-ACA minus the predicted rate of dependent variable in the 
same post-ACA year using counterfactual (that there was no ACA in that year). We 
chose determinants that we believe may modify the demand for the screening tests and 
the potential variables incorporated in the model are: age, race, income, education, 
marital status, region, health insurance type, physical activity, smoking status, 
comorbidity, routine medical checkup, metropolitan area, out-of-pocket expenses, and the 
availability of a usual source of care. It is important to note that there are few 
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determinants of cancer screenings are likely to change due to the introduction of ACA, 
implying that incorporating these variables for the post-ACA sample to define the 
counterfactual will underestimate the effect of ACA because some of these determinants 
that are affected by ACA will pick-up some of the changes happened due to the 
implementation of ACA. Most important variables likely to change due to the 
implementation of ACA are coverage rate of health insurance and types of insurance 
people have. To ensure that the counterfactual estimates are not biased, insurance type 
and coverage rates should be kept the same in the post-ACA year as it was in the pre-
ACA year. This was done through adjusting the sampling weights so that pre- and post-
ACA insurance coverage and types of insurance coverage are the same.  The dollar value 
in the out-of-pocket variable was adjusted for inflation using MCPI with 2016 as the base 
year. 
Outcome 
The outcomes are the self-reported receipt of mammogram and pap test as 
measured in the MEPS database. For each preventive service, respondents were asked 
“About how long has it been since you had this mammogram/Pap test?” with possible 
responses being “within past year,” “within past 2 years,” etc. In accordance with 
screening guidelines, a dummy variable was created for mammogram utilization equal to 
1 if the test was taken within 1 to 2 years, and a dummy variable for pap test utilization 
equals to 1 if the test was taken within 1 to 3 years.   
Statistical analysis 
Univariate analyses will be done to produce descriptive statistics of women’s 
characteristics before and after the implementation of ACA in the sample. The main 
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statistical modeling will be based on a regression equation explaining the variability of 
the dependent variables in pre-ACA period using a number of determinants or 
explanatory variables. The equations estimated can be written as: 
𝑌𝑖0 =  𝛽0 + ∑ 𝛽𝑗𝑋𝑖𝑗0, where Yio is the value of dependent variable for individual i 
for the pre-ACA year 0 and [Xj] is a set of potential determinants of Y. This estimated 
model was then used to predict the dependent variable for the post-ACA years using the 
values of determinants in the post-ACA data set. In other words, we have predicted the 
values of Y for the post-ACA year t using the estimates of b from the pre-ACA year.  
𝑌𝑖𝑡 =  𝛽0̂ + ∑ 𝛽?̂?𝑋𝑖𝑗𝑡 
The estimated coefficients b obtained for pre-ACA year will be used to predict the 
values of dependent variable for individuals in post-ACA year, the year t. Another 
regression model was estimated to predict the values of Y in post-ACA year using post-
ACA data.  The effect of ACA will be estimated as the value of dependent variable in the 
post-ACA year minus the predicted value of the dependent variable in the post-ACA year 
using the regression model obtained using pre-ACA year (the counterfactual). A positive 
difference means that women in post-ACA used more mammography and pap tests 
compared to pre-ACA year given various determinants of the dependent variable. Since a 
number of potential determinants of dependent variable may be affected by the 
introduction of ACA-triggered changes, these variables should be kept constant at the 
pre-ACA level. These variables are related with insurance coverage and types of 
insurance under which the individuals are covered. We have kept the values of these 
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determinants constant in relative terms at the pre-ACA level by changing the sampling 
weights proportionately.  
To assess the diagnostic/predictive accuracy of our logistic model, we used the 
area under the ROC curve measure. Third, we regressed the difference of the dependent 
variable, the estimated effect of ACA adoption, on some population characteristics to 
examine how different individual characteristics affect the outcome. Differences were 
considered statistically significant if P-value of the t-statistics <0.05. All statistical 
analysis will be carried out using STATA software version 14 (2015; Stata 14.0 
Statistical Software, College Station, TX, USA The analyses accounted for probability 
weighting in the MEPS (99,100). 
Results 
Table 5.1 shows descriptive statistics of the women’s characteristics in pre and 
post ACA. Women in pre-ACA and post-ACA seem to have similar distribution of the 
demographic characteristics including age, income, education, race, and insurance status, 
and the availability of usual source of care (Table 5.1). Figure 5.2 shows the results from 
the area under the ROC curve measure for our estimation models which indicate that both 
estimating models had an area under the curve was above 74%. Tables 5.2 shows the 
counterfactual analysis results which found that the utilization of mammogram and pap 
test did not increase following the ACA. Women in post-ACA used less mammography 
and pap tests than the same period post-ACA counterfactual (Table 5.2). The difference 
for mammography is -2.31 and for pap test is -5.65 (Table 5.2). Table 5.3 and 5.4 breaks 
down those differences by age, race, income, education, and health insurance type. A 
positive difference indicates that this particular group decreases the difference while a 
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negative difference indicate that this particular group increases the difference. For most 
categories, the difference was negative except for women aged 50-64 and women with 
public insurance the difference was positive which means that women in post-ACA aged 
50-64 or have public insurance used more mammogram and pap test than those in pre-
ACA (Table 5.3). Similarly, women in post-ACA used less pap tests in all sub-groups 
when compared to the same period post-ACA counterfactual (Table 5.4). Table 5.5 
shows that difference in probabilities was statistically significant. 
Discussion  
Because cost-sharing was found reducing the use of medical care services, 
particularly preventive care services, the ACA required private health insurers and 
Medicaid to cover preventive screenings recommended by the USPSTF without cost-
sharing to increase the use of these services. This study used a counterfactual analysis to 
try to understand if the ACA’s cost-sharing provisions impacted mammograms and Pap 
tests rates. In the years preceding the ACA, there was a trend of decline in both 
mammogram and Pap test use among women in the U.S. (103). Our results show that the 
introduction of free preventive services did not change the overall declines in 
mammograms and Pap tests. These results are consistent with previous studies that found 
little impact of the cost-sharing provision on mammography and pap tests rates. For 
example, Hong et al. (94) found decreased rates of being up-to-date on mammograms and 
Pap tests among those with private insurance after the ACA. Several other studies 
examined the initial impact of the removing cost-sharing on privately insured women and 
found no change in mammography and pap test (88–90). Our results show no impact on 
mammography use among women with Medicare (Table 5.3). Previous studies that 
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looked at Medicare population gave mixed results regarding mammography utilization 
after the ACA. For example, Jensen et al. (92) found minimal change in mammography 
use among older women, while other studies found statistically significant increase in 
mammography uptake after the ACA (86,87). Our analysis show positive results in 
mammogram rates for women aged 50-64 (Table 5.3). This is consistent a previous study 
that that assessed the policy from a health system level and found the ACA provisions 
were associated with increased screening volumes among women age 50-74 (93). There 
is evidence that mammogram decrease breast cancer mortality among women aged 50-69 
but the benefit of mammography for women aged 40-49 years is uncertain (22,23). Our 
results show that younger women used more Pap tests than older women (Table 5.4). 
This is consistent with the guidelines and the evidence suggesting benefits from Pap tests 
are more evident for younger women (127). Our results show that black women had the 
lowest decline in mammography and women from other minorities had the lowest decline 
Pap test use as compared to white women (Table 5.3 and Table 5.4). A recent study 
found the ACA provision to be associated with improved mammography and pap tests 
among Hispanics and African Americans (95). Looking at overall utilization, black 
women had the highest rate of mammogram and pap tests use (mammogram: 81.48%, 
pap tests: 74.73%) (Table 5.3 and Table 5.4). Evidence show that black women in the 
U.S. are more likely to diagnosed and die from breast and cervical cancer as compared to 
white women, which may explain the increased use of screenings among this group 
(128,133). 
There are some possible explanations for the little impact of the ACA cost-sharing 
provision on improving the declining rates of mammography and pap tests. First, it is 
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important to recognize that the ACA cost-sharing provision was found to be effective in 
improving other kind of preventive services such as blood pressure check, cholesterol 
check, and flu vaccination, but not cancer screenings (134). This is probably because the 
guidelines for mammograms and Pap tests were updated around the time of the ACA’s 
provisions. The guidelines for mammograms were updated in 2009 to recommend 
mammograms for women aged 50-75 every 2 years updating the previous guidelines that 
recommends screening every 1-2 for women aged 40 and older. The guidelines for 
cervical cancer screenings was updated in 2012 to recommend the Pap test for women 
aged 21-65 every three years updating the previous guidelines that recommended 
screening annually for women who are sexually active. These guidelines updates that 
occurred around the same time as the ACA provisions may have led to overall declines in 
cancer screenings. In addition to the changing guidelines, the very nature of 
mammograms and Pap tests that some women find toxic or painful may discourage them 
from getting the tests (119–122). Sometimes mammograms find false positives that carry 
risks including pain, anxiety, and other side effects. Similar to mammograms, Pap tests 
may come with harm when abnormal results lead to vaginal bleeding, pain, infection, and 
anxiety. Physicians make trade-offs between benefits and risks when making 
recommendations about who should be screened. 
Second, the impact of removing cost-sharing may have been alleviated because 
mammography and Pap tests were likely to be covered by some private insurance plans 
with no or minimal cost-sharing before ACA. The amount of cost-sharing under 
Medicare was also small (20% cost sharing). Also, women were likely to get the 
screenings through national programs such as CDC’s National Breast and Cervical 
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Cancer Early Detection Program (BCCEDP). The program was established in 1990 to 
provide free and/or reduced cost mammograms and pap test to women with limited 
incomes and those who lack health insurance. The program remained providing large 
number of screenings to women in the years following the ACA (135). 
Third, in the years before the ACA, women who are low-income were less likely 
to receive possibly lifesaving recommended cancer screenings (35). A new study found 
that the ACA was associated with improvements in health care-related financial strain 
(136). However, socioeconomic disparities remained in term of mammograms and Pap 
tests utilization. In our cohort, the majority of screenings occurred among the high-
income high-educated women (Table 5.3 and Table 5.4). This is probably due to better 
health literacy, awareness, and availability of time and transportation. Our analysis show 
that the proportion of women who reported having a usual source of care used more 
mammogram and Pap tests than those with no usual source of care (Table 5.3 and Table 
5.4). Therefore, factors related to provider availability and access may be more effective 
in improving utilization rates.  
Finally, it is important to recognize that, although screening numbers did not 
improve following the ACA, disease burden from breast and cervical cancer has been 
declined over the years. Breast cancer rates have been declining steadily in the past 
decade. Similarly, cervical cancer cases have declined rapidly in past 40 years due to 
wide use of Pap tests, however, declines in cervical cancer cases have slowed down in 
recent years. 
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Conclusion  
Following the removal of cost-sharing under the ACA, no improvement was 
observed in mammography or pap tests rate. It is important to recognize that rates of 
mammograms and Pap tests were already in a declining trend in the years before the 
ACA. The introduction of the ACA provision did not help change the decline. The 
rationale behind the ACA was built on the notion that cost-sharing hinders the use of 
preventive care services. Several post-ACA studies found positive impact on certain kind 
of preventive care services such as blood pressure check, cholesterol check, and flu 
vaccination, but not cancer screenings. In the discussion section above we provided some 
possible explanation for the lack of impact of cost-sharing removal provision on 
mammograms and Pap tests rates. 
It appears that financial barrier was not the most important factor in affecting 
utilization of these screening tests. The results indicate - as well as previous studies - that 
the higher level of utilization rates are observed among the wealthiest and most educated 
women even after the services became free after the policy change. Therefore, policy 
makers should focus efforts on facilitating access, health promotion, and awareness 
which may help improve screening rates. Future research is recommended to look at 
indicators of access to care, provider availability and characteristics, physician 
compliance to guidelines to better understand the reasons for lack of effects of cost 
reductions on utilization of cancer screenings. 
We acknowledge several limitations of this study. First, information about 
outcomes relied on self-reported survey responses which might be subject to recall error. 
However, the MEPS follow up with health providers to reduce measurement errors but 
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some errors may remain, especially for procedures and tests requiring longer recall. 
Second, the data used in the analysis are cross-sectional and comparison of cross-
sectional data of different years is not same as observing changes in the outcomes of the 
same set of individuals over the years with the implementation of the ACA. The study 
design made an attempt to tease-out the effect of policy changes. Third, a longer time 
frame may be needed to be able to see the effects of the policy changes on these 
outcomes. Fourth, for the privately insured population, there is no information on the 
coverage of screenings as health plans that were grandfathered were not subject to the 
ACA provision. Because the elimination of cost-sharing is not universal for the privately 
insured, full effect of removal of cost sharing will not be observable for this population 
group.  
Another important factor for the lack of positive effect of cost-sharing removal 
may be due to changes in the USPSTF guidelines for breast cancer and cervical screening 
that occurred around the same time as the ACA provisions. The change in the guidelines 
may have led to overall declines in cancer screening. In 2009 the guidelines for breast 
cancer screenings was updated to recommend biennial screening instead of every 1-2 
years. Also, in 2012 the USPSTF guidelines for cervical cancer was updated to 
recommend the test every 3 years instead of every year. If the physicians start using the 
new guidelines, mammogram and Pap test screenings may appear lower if prior guideline 
based utilization rates are calculated and compared. Counterfactual analysis will not be 
able to correct for the changes in screening guidelines unless a control group can be 
identified for comparative purposes.  
 59 
In any case, the analysis raises the concern that implementation of ACA’s cost 
share removal has not been effective in improving cancer screening rates and longitudinal 
survey data would be needed to understand why the removal of out of pocket costs failed 
to show the intended effects. Unfortunately, the data we have are repeated cross-
sectional. Longitudinal data covering a period of four to five years are not available to 
conduct an analysis to find out how the utilization of cancer screening tests changed for 
the same individual over the years.  
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                 Figure 5.1 Inclusion and exclusion criteria flow chart 
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     Figure 5.2 Area under the ROC curve for the estimating models 
 
 
 
Table 5.1 Descriptive statistics of the characteristics of women aged >= 21 in pre-ACA 
(2009) and post-ACA (2016), MEPS database 
 
Characteristics 
Pre-ACA 
n = 13,146 
Post-ACA 
n = 12,786 
% % 
Age  Mean 47 48 
Race   White 68 68 
Black 21 20 
Other  9 11 
Education Some school 21 19 
High School 31 29 
College  47 50 
Income Low 42 42 
Middle 29 27 
High  27 29 
Insurance Private 57 57 
Public  24 30 
Uninsured 18 11 
Usual source of 
care 
Available  77 77 
Not available  22 22 
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Table 5.2 The difference in mammography and Pap tests use between post-ACA and 
post-ACA counterfactual 
 
Post-ACA 
counterfactual 
Predicting probabilities using 2009 
model 
Post-ACA 
 
Predicting probabilities using 2016  
model 
Difference 
Mammogram 71.67% 69.36 % -2.31 
Pap test 79.42%  73.77% -5.65 
 
Table 5.3 The difference in mammography use between post-ACA and post-ACA 
counterfactual, by different population groups   
Category Post-ACA 
counterfactual 
Predicting probabilities using 
2009 model 
Post-ACA 
 
Predicting probabilities using 
2016  model 
Difference 
Low income 62.29% 60.62% -1.67 
Middle income 71.15% 69.82% -1.33 
High income  82.40% 78.56% -3.84 
Some school 60.61% 57.23% -3.38 
High school 68.31% 68.08% -0.23 
College  78.33% 75.21% -3.12 
White 70.56% 68.46% -2.1 
Black 76.24% 74.73% -1.51 
Other 70.73% 65.57% -5.16 
40-49 65.50% 60.96% -4.54 
50-64 74.98% 75.52% +0.54 
>=65 72.49% 69.38% -3.11 
Private insurance  77.70% 74.92% -2.78 
Public insurance 66.64% 66.70% +0.06 
Uninsured  42.75% 39.50% -3.25 
Available USC 76.03% 72.82% -3.21 
Not available USC 45.33% 49.96% -4.63 
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Table 5.4 The difference in Pap tests use between post-ACA and post-ACA 
counterfactual, by different population groups 
Category Post-ACA 
counterfactual 
Predicting probabilities using 
2009 model 
Post-ACA 
 
Predicting probabilities using 
2016  model 
Difference 
Low income 76.24% 70.22% -6.05 
Middle income 78.52% 72.68% -5.84 
High income  84.85% 79.92% -4.93 
Some school 70.46% 66.56% -3.9 
High school 75.76% 69.22% -6.54 
College  84.94% 79.14% -5.8 
White 78.16% 71.62% -6.54 
Black 85.32% 81.48% -3.84 
Other 76.71% 73.46% -3.25 
21-39 89.26% 86.17% -3.09 
40-49 86.04% 84.51% -1.53 
50-64 78.29% 73.74% -4.55 
Private insurance  83.52% 79.09% -4.43 
Public insurance 73.89% 65.44% -8.45 
Uninsured  73.13% 68.96% -4.17 
Available UCS 86.84% 83.77% -3.07 
Not available USC 79.18% 75.47% -3.71 
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Table 5.5 Likelihood of the difference between post-ACA and post-ACA counterfactual 
to increase/decrease explained by different determinants    
Category  Difference in 
mammogram 
Difference in Pap test 
Low income 0 
(.) 
0 
(.) 
Middle income 0.0256*** 
(37.05) 
0.000804 
(0.95) 
High income  -0.00406*** 
(-5.58) 
0.0345*** 
(34.70) 
Some school 0 
(.) 
0 
(.) 
High school 0.0298*** 
(37.44) 
-0.0204*** 
(-19.26) 
College 0.0120*** 
(15.32) 
-0.0280*** 
(-28.37) 
White 0 
(.) 
0 
(.) 
Black -0.0196*** 
(-24.37) 
0.0249*** 
(33.66) 
Other 
 
-0.0386*** 
(-38.73) 
0.0155*** 
(17.02) 
21-39  
 
0 
(.) 
40-49 
 
0 
(.) 
0.00758*** 
(9.81) 
50-64 0.0554*** 
(67.09) 
-0.0303*** 
(-35.82) 
>=65 0.0284*** 
(32.22) 
 
Private insurance  0 
(.) 
0 
(.) 
Public insurance 0.0285*** 
(42.36) 
-0.0187*** 
(-20.24) 
Uninsured  -0.0279*** 
(-19.43) 
-0.0191*** 
(-13.70) 
Cons_ 
 
-0.0651*** 
(-36.92) 
-0.0149*** 
(-8.80) 
N 6364             8924 
t statistics in parentheses 
* p<0.05, ** p<0.01, *** p<0.001 
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CHAPTER 6  
CONCLUSION 
 
The Patient Protection and Affordable Care Act of 2010 aimed at making health 
care affordable for different sectors of the population and improving access to the needed 
health care services including the use of preventive care services. Increased use of 
preventive care services will in turn reduce costly events from poorly or unmanaged 
chronic conditions. Among the strategies adapted by the ACA to achieve these aims; the 
Medicaid coverage expansion and the removal of cost-sharing for recommended 
preventive care services. To reduce the number of the uninsured population and improve 
access to care among the low-income population, the ACA expanded the coverage of 
Medicaid to include the entire population aged 18-64 with income below 138% of federal 
poverty line (1). In the years before the ACA, most uninsured population were low-
income and therefore the Medicaid coverage expansion has the potential to improve 
access for low-income population to the needed health care services. As a result of the 
Medicaid coverage expansion, 11 million were newly eligible in Medicaid (43). There are 
many post-ACA studies that found the expansion associated with improved coverage, 
access, and affordability (61–69). In addition, the ACA required private health insurers 
and Medicare to cover recommended preventive screenings without cost-sharing. In years 
before the ACA, the percentage of American women who receive mammograms and pap 
tests has been suboptimal (2). It has been documented in the literature that health care 
coverage or cost-sharing were associated with the use of medical services including 
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preventive care services (3–15). The removal of cost-sharing from recommended 
preventive services has the potential to improve the use of these services. There are many 
post-ACA studies that found the cost sharing provision associated with improved 
preventive care use. The impact of both provisions on mammograms and Pap tests were 
mixed (108–111,134,137–145).  
Medicaid expansion 
The difference-in-differences analysis showed that expansion of Medicaid under 
the ACA was associated with increased Medicaid enrollment but did not yield near-term 
improvements in the use of mammography and Pap tests among low-income women. 
Although the difference-in-differences did not show improvements in mammograms and 
Pap tests due to Medicaid expansion under ACA, low-income women living in expansion 
states used higher level of screenings than their counterparts in non-expansion states. In 
DID, lack of any positive results is due to pattern of changes happened in screening rates 
in expansion and non-expansion states. In expansion states, the increase in screening rates 
were either lower or negative. Since Medicaid expansion did not affect these screening 
tests, policy makers need to examine other factors that may act as barriers in improving 
access and utilization. Some possible explanations for this lack of impact of the Medicaid 
expansion on mammograms and Pap tests are presented in chapter four but we have no 
concrete evidence to conclusively say which factors have affected access to screening 
tests adversely in the expansion states compared to non-expansion states. It is also 
possible that a longer timeframe will be needed for a change to be manifested but this 
study only looked at three years after the policy change. Future research on provider 
availability and characteristics, insurance types, and geographical variations is warranted 
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for a better understanding of the use of cancer screening procedures by the poor women 
in the USA. 
Cost-sharing removal 
Following the removal of cost-sharing under the ACA, no improvement was 
observed in mammography or pap tests rate. It is important to recognize that rates of 
mammograms and Pap tests were already in a declining trend in the years before the 
ACA. The introduction of the ACA provision did not help change the decline. The 
rationale behind the ACA was built on the notion that cost-sharing hinders the use of 
preventive care services. Several post-ACA studies found positive impact on certain kind 
of preventive care services such as blood pressure check, cholesterol check, and flu 
vaccination, but not cancer screenings. In chapter five we provided some possible 
explanation for the lack of impact of cost-sharing removal provision on mammograms 
and Pap tests rates. 
 It appears that financial barrier was not the most important factor in affecting 
utilization of these screening tests. The results indicate - as well as previous studies - that 
the higher level of utilization rates are observed among the wealthiest and most educated 
women even after the services became free after the policy change. Therefore, policy 
makers should focus efforts on facilitating access, health promotion, and awareness 
which may help improve screening rates. Future research is recommended to look at 
indicators of access to care, provider availability and characteristics, physician 
compliance to guidelines to better understand the reasons for lack of effects of cost 
reductions on utilization of cancer screenings. 
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Limitations  
We acknowledge some important limitations of this study. First, information 
about outcomes relied on self-reported survey responses which might be subject to recall 
error. However, the MEPS follow up with health providers to reduce the reporting errors 
but some errors may still remain, especially for procedures and tests requiring longer 
recall time frame. Second, the data used in the analysis are cross-sectional and 
comparison of cross-sectional data at different years is not same as observing changes in 
the outcomes with the implementation of ACA. In the Medicaid expansion study, the 
design made an attempt to tease-out the effect of policy changes through DID and in most 
cases DID approach can identify the effect of policy change even when the starting 
characteristics of the control and intervention groups are significantly different. Third, 
since repeated cross-sectional survey data were used, it was not possible to show the 
pathways of outcome variation, i.e., the effect of ACA on Medicaid enrollment and effect 
of Medicaid enrollment on the outcomes of interest. Fourth, there were changes in the 
USPSTF guidelines for breast cancer and cervical screening that occurred around the 
same time as the ACA provisions which may have led to overall declines in cancer 
screening. In 2009 the guidelines for breast cancer screenings was updated to recommend 
biennial screening instead of every 1-2 year screenings. Also, in 2012 the USPSTF 
guidelines for cervical cancer was updated to recommend the test every 3 years instead of 
every year. Fifth, national programs providing these tests to poor women may have 
dampen the effect of the policy change and if the national program in post-policy change 
years provided more emphasis on covering screenings in non-expansion states, it can 
potentially offset any positive effects of Medicaid expansion when estimated through 
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DID modeling. In any case, this lack of relative improvements in cancer screenings in the 
Medicaid expansion states (compared to non-expansion states) is perplexing and would 
require supplementing the national data with other program effects and other structural 
differences between these two groups of states. Sixth, for the privately insured 
population, there is no information on the coverage of screenings as health plans that 
were grandfathered were not subject to the ACA provision. Because the elimination of 
cost-sharing is not universal for the privately insured, full effect of removal of cost 
sharing will not be observable for this population group. Finally, the data we have are 
repeated cross-sectional. Longitudinal data covering a period of four to five years are not 
available to conduct an analysis to find out how the utilization of cancer screening tests 
changed for the same individual over the years.   
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APPENDIX A 
MEDICAID EXPANSION STATUS  
State Medicaid expansion status as of September 2018 (Source: Kaiser foundation 
website) 
Medicaid 
Expansion Status 
States Start date 
Adapted Arizona, Arkansas, California, Colorado, 
Connecticut, Hawaii, Illinois, Iowa, Kentucky, 
Maryland, Minnesota, Nevada, New Jersey, New 
Mexico, North Dakota, Ohio, Oregon, Rhode 
Island, Washington, West Virginia 
Jan 2014 
Michigan Apr 2014 
New Hampshire Aug 2014 
Pennsylvania  Jan 2015 
Indiana  Feb 2015 
Alaska Sep 2015 
Montana Jan 2016 
Louisiana 
Virginia 
Maine 
Jul 2016 
Jan 2019 
TBD 
Did not adapt Alabama, Florida, Georgia, Kansas, Mississippi, 
Missouri, North Carolina, Oklahoma, South 
Carolina, South 
Dakota, Tennessee, Texas, Wisconsin, Wyoming 
NA 
Considering Idaho, Nebraska, Utah To be 
determined 
 
States that expanded Medicaid to childless adults before 2014 (Source: Kaiser foundation 
website) 
Medicaid 
Expansion Status 
States Start date Income 
eligible 
level 
Adapted before 
2014 
District of Columbia Jul 2010 215% 
Vermont Jan 2011 160% 
New York Apr 2009 100% 
Delaware 2009 100% 
Massachusetts Apr 2009 133% 
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APPENDIX B 
PARALLEL TREND TEST RESULTS 
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